MET and hematologic disorder: Significant VEGFR expression has been reported in brain, lung, breast, and colon cancers; c-Met is associated with colon, breast, and ovarian cancers, as well as hematological malignancies; and overexpression of CXCR7 correlates with breast and lung cancer [77,80].